Subvention

Liste des articles subventionnés :
wdt_ID N° de subvention Titre Auteur Revue Année
1 964 Validation of the Moroccan arabic version of the low anterior resection syndrome score Amine SOUADKA BMC Gasgtroenterology 2020
2 966 Use of a prospective risk analysis method to improve the safety of healthcare workers in oncology hospitals during the COVID-19 spread among cancer patients Abdelali Ouasrhir European Journal of Oncology Pharmacy 2020
3 975 Cancer Omics in Africa: Present and Prospects Hassan GHAZAL Frontiers in Oncology 2020
4 984 Anxiety and Depression Comorbidities in Moroccan Patients with Breast Cancer Institutional affiliations Abdeljalil ELGOT Frontiers Psychiatry 2021
5 986 Mid-term audit of a national peritoneal surface malignancy program implementation in a low middle income country : the Moroccan experience Amine SOUADKA Cancer 2021
6 988 Psychometric Validation of the Moroccan version of the EORTC QLQ-C30 in Colorectal Cancer Patients: Cross-Sectional Study and Systematic Literature Review Amine SOUADKA BMC Cancer 2021
7 995 The Promising IgSF11 ImmuneCheckpoint Is Highly Expressed in Advanced Human Gliomas and Associates to Poor Prognosis Amina GHOUZLANI Frontiers in Oncology 2021
8 996 Injectable anticancer drugs and the risks of dispensing by community Pharmacies in Morocco Abdelali Ouasrhir European Journal of Oncology Pharmacy 2021
9 998 Updates on Clinical use of Liquid Biopsy in Colorectal Cancer Screening, Diagnosis, Follow-up, and Treatment guidance Mazouji Omayma frontiers in cell and developmental biology 2021
10 999 Tracing Ovarian Cancer Research in Morocco: A Bibliometric Analysis El Bairi Khalid Gynecologic Oncology Reports 2021
11 1011 Inexpensive Systemic Inflammatory Biomarkers in Ovarian Cancer: An Umbrella Systematic Review of 17 Prognostic Meta-analyses El Bairi Khalid Frontiers in Oncology 2021
13 1012 Neurocognitive state and quality of life of patients with glioblastoma in Mediterranean countries: A systematic review BABA MOHAMED AMINE Annals of Palliative Medicine 2021
14 1014 Prognostic Gene Expression Signature in Patients With Distinct Glioma Grades AIT SSI SAADIA Frontiers in Immunology 2021
15 1024 Bevacizumab in Metastatic Colorectal Cancer in a Real-Life Setting: Toxicity Profile, Survival Outcomes, and Impact of Tumor Sidedness El Bairi Khalid Contemporary Oncology 2021
16 1033 Dietary fat intake and KRAS mutations in colorectal cancer in a Moroccan population Achraf EL ASRI Nutrients 2022
17 1044 The Prognosis and Predictive Value of Estrogen Negative/Progesterone Positive (ER/PR+) Phenotype: Experience of 1159 Primary Breast Cancer from a Single Institut EL FATEMI HIND The Breast Journal 2022
18 1045 Molecular and Circulating biomarkers in patients with Glioblastoma Sanae BENNIS International Journal of Molecular Sciences 2022
19 1046 Evaluation of the implementation of a quality improvement program through morbidity and mortality reviews in a developing country ANASS Majbar Annals of Medicine and Surgery 2022
20 1050 Molecular classification of soft tissue sarcomas for adequate diagnosis: A study on the northeast population of Morocco Rhizlane El Koubaiti Heliyon 2022
21 1051 BTN3A: A Promising Immune Checkpoint for Cancer Prognosis and Treatment Abdallah Badou International Journal of Molecular Sciences 2022
22 1063 Audit of laparoscopic surgery for colon cancer in Morocco: A report of the results of a prospective multicentre cohort study ANASS Majbar Annals of Medicine and Surgery 2022
23 1064 Genetic polymorphisms in ERCC1 gene and their association with response to radiotherapy in Moroccan patients with nasopharyngeal carcinoma Mohammed EL MZIBRI Asian Pacific Journal of Cancer Prevention 2022
24 1066 Assessment of lipid peroxidation status in serum of Moroccan patients with nasopharyngeal carcinoma Meriem KHYATTI Contemporary Oncology 2022
25 1067 Prognostic factors for survival of patients with glioblastoma in the southern region of Morocco BABA MOHAMED AMINE Archives of Neuroscience 2022
26 1068 CAR T-cells for colorectal cancer immunotherapy: Ready to go? GHAZI Bouchra Frontiers in Immunology 2023
27 1069 Clinical evidence of circulating tumor DNA application in ag-2 gressive breast cancer Sanae BENNIS Diagnostics 2023
28 1071 Metagenomics analysis of breast microbiome highlights the abundance of Rothia genus in tumor tissues KARTI Souad Journal of personalized medicine 2023
29 1072 Epidemiological, Clinicopathological and Prognosis Features of Moroccan Patients with Nasopharyngeal Carcinoma Meriem KHYATTI Asian Pacific Journal of Cancer Prevention 2023
30 1074 A2AR as A Prognostic Marker and A Potential Immunotherapy Target in Human Glioma RAFII Soumaya International Journal of Molecular Sciences 2023
31 1075 Epidemiology of monoclonal gammopathy in Morocco- A hospital-based study Running Head: Monoclonal gammopathy EL MAATAOUI Aissam CANCER REPORTS 2023
32 1076 The evaluation of Vascular Endothelial Growth Factor A (VEGFA) and VEGFR2 receptor as prognostic biomarkers in bladder cancer Mohammed EL MZIBRI Diagnostics 2023
33 1078 Prevalence of Polyomaviruses and Herpesviruses in Moroccan Breast Cancer Meriem KHYATTI Pathogens 2023
34 1082 New Biomarkers and Treatment Advances in Triple-Negative Breast Cancer Sanae BENNIS Diagnostics 2023
35 1083 Association between single nucleotide polymorphisms in DNA repair genes and the efficacy of radiotherapy in nasopharyngeal carcinoma patients Imane CHAOUI Contemporary Oncology 2023
36 1085 High VISTA expression is linked to a potent epithelialmesenchymal transition and is positively correlated with PD1 in breast cancer REZOUKI IBTISSAM Frontiers in Oncology 2023
37 1086 A comparative analysis of NOX4 protein expression in malig-2 nant and non malignant thyroid tumors. Rabii AMEZIANE EL HASSANI Current Issues in Molecular Biology 2023
38 1087 The Tumor Suppressor BRCA1/2, Cancer Susceptibility and Genome Instability in Gynecological and Mammary Cancers Yassire Oubaddou Asian Pac J Cancer Prev 2023
39 1135 Factors associated with psychological burden of breast cancer in women in Morocco: cross-sectional study Safia MALHAQ BMC Women's Health 2023
40 1255 COMPARISON OF DIFFERENT PANCREATIC CANCER TREATMENTS: A THREE-YEAR RETROSPECTIVE STUDY IN THE ONCOLOGY CENTER OF TANGIER UNIVERSITY HOSPITAL, MOROCCO ABRINi, HOUDA BMC Gasgtroenterology 2023
41 1408 Glioblastoma vaccines as promising immune-therapeutics : challenges and current status Sanae BENNIS Vaccines 2024
42 1412 Shifting Paradigms in TNBC Treatment: Emerging Alterna-2 tives to Capecitabine in the Post-Neoadjuvant Setting HALIMA ABAHSSAIN CURRENT ONCOLOGY 2024
43 1413 Is the development of liquid biopsy for the early detection and the monitoring of breast cancers on its way of overtaking mammography? Hicham MANSOUR Frontiers in Medecine 2024
44 1415 Cross-Cultural Adaptation and Pilot Psychometric Validation of the European Organisation for Research and Treatment of Cancer—Quality of Life Questionnaire—Sexual Health (EORTC QLQSH22) Scale, Moroccan Arabic Version Safia MALHAQ Healthcare 2024
45 1419 Investigating the Availability, Affordability, and Market Dynamics of Innovative Oncology Drugs in Morocco: An Original Report Nada BENHIMA International Journal for Equity in Health 2024
46 1433 Neurocognitive function and healthrelated quality of life among glioblastoma patients from Southern region of Morocco, North Africa” Amine Mohamed BABA Journal of Public Health in Africa (JPHIA) 2024
47 1496 High expression of BTN3A1 is associated with clinical and immunological characteristics and predicts a poor prognosis in advanced human gliomas Abdousamad KONE Frontiers in Immunology 2024
48 1527 Deciphering immune microenvironment and cell evasion mechanisms in human gliomas RAFII Soumaya Frontiers in Oncology 2024
49 1650 Beyond tumor borders: Intratumoral Microbiome effects on tumor behavior and therapeutic responses HARMAK, ZAKIA Immune Network 2024
50 1687 The immune checkpoint VISTA is associated with prognosis in patients with malignant uveal melanoma ISSAM SALAH , Nour el imane Frontiers in Immunology 2024
N° de subvention Titre Auteur Revue Année
Menu